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Abstract
Background: The neuronal nicotinic receptors that mediate excitatory transmission in autonomic ganglia are thought to be
formed mainly by the a3 and b4 subunits. Expressing this composition in oocytes fails to reproduce the properties of
ganglionic receptors, which may also incorporate the a5 and/or b2 subunits. We compared the properties of human a3b4
neuronal nicotinic receptors expressed in Human embryonic kidney cells (HEK293) and in Xenopus oocytes, to examine the
effect of the expression system and a:b subunit ratio.
Methodology/Principal Findings: Two distinct channel forms were observed: these are likely to correspond to different
stoichiometries of the receptor, with two or three copies of the a subunit, as reported for a4b2 channels. This interpretation
is supported by the pattern of change in acetylcholine (ACh) sensitivity observed when a hydrophilic Leu to Thr mutation
was inserted in position 99 of the second transmembrane domain, as the effect of mutating the more abundant subunit is
greater. Unlike a4b2 channels, for a3b4 receptors the putative two-a form is the predominant one in oocytes (at 1:1 a:b
cRNA ratio). This two-a form has a slightly higher ACh sensitivity (about 3-fold in oocytes), and displays potentiation by zinc.
The putative three-a form is the predominant one in HEK cells transfected with a 1:1 a:b DNA ratio or in oocytes at 9:1 a:b
RNA ratio, and is more sensitive to dimethylphenylpiperazinium (DMPP) than to ACh. In outside-out single-channel
recordings, the putative two-a form opened to distinctive long bursts (100 ms or more) with low conductance (26 pS),
whereas the three-a form gave rise to short bursts (14 ms) of high conductance (39 pS).
Conclusions/Significance: Like other neuronal nicotinic receptors, the a3b4 receptor can exist in two different
stoichiometries, depending on whether it is expressed in oocytes or in mammalian cell lines and on the ratio of subunits
transfected.
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Introduction
Heterologous expression of muscle nicotinic receptors produces
recombinant channels whose properties are similar to those of
native channels from the neuromuscular junction. These proper-
ties are broadly similar for channels expressed in the two main
heterologous expression systems, Xenopus oocytes and mammalian
cell lines. The situation is different for the other main form of
nicotinic receptor at peripheral synapses, the ganglion receptor.
The main subunits contributing to this channel are a3 and b4
(probably together with a5 and b2 [1–3]). Receptors expressed in
oocytes from these subunits resemble those from native autonomic
ganglia in macroscopic pharmacology [4], but are very different at
single-channel level. Most oocyte-expressed a3b4 channels open to
a smaller conductance and produce much longer bursts than
native receptors [5]. When the a3 and b4 subunits were stably
transfected in mouse fibroblasts at a 1:1 ratio, our outside-out
recordings showed both oocyte-like channels and an additional,
ganglion-like class of openings [6]. At the time, we did not have an
explanation for this phenomenon, as obtaining transient expres-
sion of neuronal nicotinic subunits at sufficient levels was
problematic.
The central-type a4b2 neuronal nicotinic combination can exist
in two stoichiometries, which contain either two or three copies of
the a4 subunit in the channel pentamer [7], as first suggested by
Papke and co-workers for a2b2 [8]. The two forms of the a4b2
receptor can be distinguished in that the two-a form is activated at
much lower ACh concentrations, has a different sensitivity to other
agonists and does not display enhancement of submaximal ACh
responses in the presence of low Zn2+ concentrations [9,10]. Given
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that in the Cys-loop superfamily binding sites are at the interface
of subunits, different subunit stoichiometries result in pharmaco-
logical differences in binding sites (see for GABAA receptors [11]).
Earlier work on oocytes injected with a3 and b4 subunit cRNA
has indicated the presence of a heterogeneous channel population
[12]. Here we present evidence that a3b4 receptors, like the a4b2
receptor, can also exist in two different stoichiometries, whose
different properties explain our old results [5,6]. This is shown by
data from receptors containing 99 reporter mutations in either the
a or b subunit in both oocytes and transiently-transfected
HEK293 cells. We also provide a characterisation of the two
forms of the a3b4 receptor, exploiting the fact that the
stoichiometry of oocyte-expressed receptors can be manipulated
by changing a:b cRNA ratios. When injections are carried out
with equal amounts of a3 and b4 cRNA, the putative two-a form
of the channel predominates in oocytes [13], whereas the three-a
form is more abundant in HEK cells. The most distinctive
macroscopic property of the two-a form is that it displays both
potentiation and inhibition in response to Zn2+ (only inhibition is
observed in the three-a form). In addition to that, single-channel
recordings from HEK cells indicate that the ‘‘oocyte-like’’ long-
burst, low-conductance channel corresponds to the two-a form,
whereas the short-burst, high conductance class (‘‘ganglion-like’’,
see [5,6]) reflects the activity of pentamers containing three a
subunits.
Results
Human a3b4 nAChR expressed in HEK293 cells contain
three a subunits
HEK293 cells were transfected with equal amounts of the a3
and b4 subunit cDNA to express a3b4 receptors. We char-
acterised the change in ACh sensitivity caused by introducing a
reporter mutation in either the a or the b subunit (see Figure 1).
This mutation (99 LT) replaces the conserved leucine in the
middle of the pore-lining second transmembrane domain (M2)
with a hydrophilic threonine and increases agonist potency in a
manner proportional to the number of mutations in the channel
[13,14]. The dose-response curves in Figure 1B (obtained from
the peak inward currents elicited by ACh, see the traces in panel
A) show that the greater shift in ACh potency is seen when the
mutation is in the a subunit. Thus, a3LTb4 receptors are almost
20 times more sensitive to ACh than wild-type channels, with an
EC50 of 5.560.9 vs. 91.1610.7 mM, respectively (n=7 and 8,
respectively, see Table 1). Mutating the b subunit had a
significantly smaller effect, reducing EC50 by about 5-fold, to
18.661.9 mM for a3b4LT receptors (n=6; significance from the
confidence intervals for the potency ratios, Table 1). This strongly
suggests that HEK-expressed a3b4 receptors contain more a
than b subunits, in contrast with our observations in oocyte-
expressed a3b4 receptors, where the same approach indicated a
2a:3b stoichiometry [13].
Injection of oocytes with different a:b cRNA ratios
produces receptors with different stoichiometry
In our previous work in oocytes, cells were injected with equal
amounts of a3 and b4 subunit cRNA [4,5,13]. More recent studies
proved that changing the expressed ratio of a:b changes the
subunit stoichiometry of a4b2 nicotinic receptors in oocytes [9,15]
and we hypothesised that this may occur also for a3b4 receptors.
Figure 2 shows inward currents elicited by ACh in oocytes
expressing a3LTb4 or a3b4LT receptors at a:b cRNA injection
ratios of 1:9 and 9:1 and the respective dose-response curves.
When a subunit ratio of 1a:9b was used (left side of Figure 2),
mean EC50 values were very similar to those observed when equal
amounts of a and b cRNA were injected (Table 2 and [13]). In
particular, the greater increase in agonist sensitivity, approximate-
ly 150-fold, occurred when the reporter mutation was inserted in
the b subunit (top half of Table 2). The effect of the mutation on
the ACh dose-response curve was very different when the a
subunit cRNA was injected in a 9-fold excess to the b subunit
(right side of Figure 2). This time the pattern was similar to that
seen for receptors expressed in mammalian cells, as the greater
increase in ACh sensitivity was seen for a3LTb4 receptors, with a
leftward shift of 47-fold (bottom of Table 2), significantly greater
than the 10-fold shift produced by inserting the mutation in the b
subunit (cf. the confidence intervals shown in Table 2). This is
what would be expected if excess a cRNA forces the oocyte to
produce receptors with a three-a and two-b stoichiometry, and
overrides the oocyte tendency to express receptors with two a and
three b in the pentamer.
In the simplest case of a symmetrical channel made of
equivalent subunits, each mutation copy would produce an equal
‘‘unitary’’ change in the free energy of gating, and hence a r-fold
‘‘unitary’’ change in EC50 values. Two or three copies of the
mutation would shift EC50 by r
2 or r3-fold, respectively. This
gives rise to a linear relation between the logarithm of the EC50
values and the number of mutant subunits incorporated in the
pentamer. Figure 3 shows that this relation holds for HEK- and
oocyte-expressed receptors with up to three copies of the
mutation. These data are consistent with our interpretation that
a3b4 receptors from HEK and from oocytes injected with the
9:1 a:b ratio contain three copies of the a subunit, whereas
receptors from oocytes injected with a 1:1 or a 1:9 ratio contain
only two copies of the a subunit. Note also that our estimates of
the elementary change in EC50, r (from the square or cube root
of the potency ratios), are similar for putative three-a receptors
whether they are expressed in HEK or in oocytes (see Tables 1
and 2).
Our results on a3b4 receptors, therefore, agree with those on
a4b2 receptors [9,15]: depending on the a3 to b4 cRNA ratio
used, oocytes can express receptors that contain either two or three
copies of the a subunit in the pentamer.
Receptors expressed in oocytes with a ratio of 1:9 and 9:1
have different sensitivity to DMPP
The EC50 values in Table 2 also show that wild-type a3b4
receptors expressed with extreme ratios have different ACh
sensitivity, 137.8613.7 vs. 309.5627.8 mM (n=4 for both,
p=0.0015, two-tailed Student’s t test) for the 1:9 and 9:1 ratios,
respectively. In a4b2 receptors this difference is much greater (80-
fold or more) but in the same direction [7,9]. It is possible that the
two-a and the three-a form of a3b4 differ in other properties,
some of which may be useful as tools in characterising native
receptors. We therefore characterised the sensitivity of the two
forms to a range of nicotinic agonists.
Figure 4A shows examples of inward currents elicited by low
concentrations of nicotinic agonists in oocytes injected with a ratio
of 1:9 (first row) or 9:1 a:b subunit cRNA (second row). Panel B
shows partial dose-response curves as log-log plots (effectively the
foot of the dose-response curve) to six agonists obtained in two
representative experiments (corresponding to the traces in A,
except for the lobeline responses that are from two different
experiments, see legend). If we refer to the standard agonist, ACh
(continuous lines in Fig. 4B), there are two agonists that stand out,
epibatidine and carbachol. On both types of receptors, epibatidine
is very much more potent than ACh (by more than 6000-fold),
whereas carbachol is much less potent (by about 10-fold, see
a3b4 Receptor Stoichiometry
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Table 3). The other agonists tested in these experiments, nicotine,
DMPP and cytisine, are very much closer to ACh in their potency.
Remarkably, the rank order of potency for the agonists we tested is
very similar for the putative two-a and the three-a receptors,
epibatidine&lobeline.nicotine,cytisine.ACh.carbachol, in
descending order of potency, with the single exception of DMPP
(see Table 3). DMPP and ACh were equipotent (potency ratio
0.9960.023) in 1:9 oocytes (n=9), but DMPP was ,10 times
Table 1. Effects of 99 LT mutation on the ACh dose-response curve of human a3b4 receptors expressed in HEK293 cells.
Subtype EC50 (mM) Imax (nA) Hill slope Potency ratio
Square root of
potency ratio
Cube root of
potency ratio n
a3b4 91.1610.7 6.6761.63 1.6560.23 1 - - 8
a3b4LT 18.661.93 0.4860.14 1.4360.11 5.13 [4.31–6.08] 2.26 [2.08–2.47] - 6
a3LTb4 5.5160.91 2.2160.77 1.2760.04 18.6 [15.1–22.9] - 2.65 [2.47–2.84] 7
EC50, Imax and Hill slope are means6 standard error of the mean of separate fits of each dose-response curve to the Hill equation. Potency ratios relative to the wild type
curve were estimated from the parallel fits in which the curves were constrained to have equal Hill slopes. The 2-unit likelihood intervals for the ratios are shown in
square brackets.
doi:10.1371/journal.pone.0013611.t001
Figure 1. In HEK-expressed a3b4 receptors, the 99LT mutation has a greater effect if inserted in a3. Traces in (A) are whole cell inward
currents elicited by different ACh concentrations applied to cells expressing wild type (top), a3b4LT (middle) or a3LTb4 (bottom) channels. The bars
above the traces show the duration of the agonist applications and the agonist concentration (in mM). Cells were transfected with an a3 to b4 ratio of
1:1 and held at 230 mV. Dose-response curves are shown in (B) for each receptor combination. The data were averaged after normalisation to the
fitted maximum for each experiment. The lines show Hill equation fits (see Methods) to the pooled normalised data (n=6–8).
doi:10.1371/journal.pone.0013611.g001
a3b4 Receptor Stoichiometry
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more potent than ACh (1060.62, n=8) when cells were injected
in a 9:1 ratio. The rank order of potency for the 1:9 receptors is
almost identical to the one we reported for 1:1 receptors [13], in
agreement with our conclusion from the reporter mutation
experiments that in oocytes both the 1:1 and the 1:9 ratio of
subunits give rise to receptors with two copies of a in the
pentamer.
In oocytes, Zn2+potentiation of a3b4 nicotinic currents is
not seen when the a subunit is overexpressed
In the a4b2 receptor, Zn2+ potentiation of submaximal ACh
responses is stoichiometry-specific and occurs only in receptors
with three copies of the a subunit [10]. Specific amino acids on the
a4-a4 interface are necessary for potentiation, in particular a
glutamate residue, in loop C, on the + side of the subunit-subunit
Figure 2. The effect of the 99 LT mutation in oocytes depends on the a3:b4 subunit ratio. Traces in (A) represent inward currents elicited
by different concentrations of ACh (in mM) bath applied (duration shown as a solid bar). Cells were held at270 mV. Pooled normalised dose-response
curves, fitted with the Hill equation with free parameters are shown in (B) for oocytes injected with 1:9 (left) or 9:1 (right) a3 to b4 cRNA ratio. The 1:9
subunit ratio produces wild-type receptors that are more sensitive to ACh. The effect of the mutation is greater when it is carried by the b4 subunit if
b4 is overexpressed (1:9) and when the a3 subunit is mutated if the a3 subunit is overexpressed (9:1).
doi:10.1371/journal.pone.0013611.g002
a3b4 Receptor Stoichiometry
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interface, together with a histidine residue, in loop F, on the 2
side. By analogy with the a4b2 combination, we hypothesised that
the potentiating effect of Zn2+ might be stoichiometry-specific also
in the a3b4 receptor. We verified this hypothesis by testing the
effects of Zn2+ on the two forms of a3b4 expressed in oocytes with
9:1 or 1:9 a:b cRNA ratios.
The traces in Figure 5A show the effect of increasing
concentrations of Zn2+ on the inward currents elicited by applying
ACh at EC20 to receptors with different stoichiometries. Normalised
average responses are also plotted as dose-response curves in panel
B of the Figure. As we hypothesized, no Zn2+ enhancement was
seen for the putative three-a form of the a3b4 receptor (a3b4 9:1,
filled squares in Fig. 5B): Zn2+ only inhibited ACh currents with an
IC50 of 400650 mM and an (absolute) Hill slope value of 1.460.1
(n=4). In contrast to that, Zn2+ had a complex effect on the putative
two-a form of the a3b4 receptor (a3b4 1:9, filled circles in Fig. 5B).
Lower Zn2+ concentrations (0.5 to 2 mM) enhanced ACh responses
by up to 70613% with EC50 and Hill slope values of 168.2614 mM
and 1.860.2, respectively (n=5). Concentrations higher than
2 mM inhibited ACh currents with IC50 and (absolute) Hill slope
value for the inhibition of 3.260.3 mM and 2.160.2, respectively.
Our observation that ACh responses from the putative two-a
form of a3b4 receptors can be either enhanced or inhibited,
depending on the Zn2+ concentration, agree with similar results in
oocytes injected with a3 and b4 cRNA in a 1:1 ratio [16]. This is
consistent with our finding that oocytes injected with equal
amount of a3 and b4 cRNA express preferentially the two-a form
of the receptor [13].
Receptors expressed in HEK293 cells with a ratio of 1:9
and 9:1 differ in their single-channel properties
Oocyte-expressed a3b4 channels open mostly in long bursts to a
low (22 pS) conductance [5]: the results shown above suggest that
these openings reflect the activity of a two-a form of the receptor
(see also ref. [12]). This sort of channel is common also in stably-
transfected mammalian fibroblasts, where we observed an
additional type of channel activity, with shorter bursts and a
higher conductance of 36 pS [6]. Our new data on HEK293 cells
show that they preferentially express another form of the receptor,
and raise the possibility that the short-burst, high conductance
channels correspond to a three-a stoichiometry. This hypothesis is
confirmed by the data in Figure 6.
The traces in Figure 6A are representative single-channel
currents evoked by the application of 5 mM ACh to outside-out
patches at 2100 mV. HEK cells were transfected with a3 and b4
cDNA at a ratio of 1:9 (left) or 9:1 (right). Openings in 1:9 patches
are smaller in amplitude and occur in longer bursts, resembling the
channels we characterised in oocytes, i.e. the putative two-a form
of the channel. On the other hand, for 9:1 transfected cells, two
different classes of openings occur: one is similar in amplitude and
burst length to the putative two-a form observed in the 1:9 cells,
whereas a second class opens in shorter bursts to a bigger
conductance. These two classes of openings are never linked to
each other by direct transitions (data not shown), and therefore
they are likely to be produced by different receptor molecules.
The data from the patches in Figure 6A are plotted as fitted
amplitude histograms in Figure 6B, where each opening is counted
as one data point. The continuous curves are the fits with one (1:9)
or two (9:1) Gaussian components. All patches from the 1:9
transfection had one component with average amplitude of
2.660.1 pA (corresponding to a chord conductance of 26 pS;
n=7). Low conductance openings were also present in three out of
five 9:1 patches, where their average amplitude was 2.660.1 pA
(area 2466%), but even when present were less common than
high conductance openings, which had an amplitude of
3.960.04 pA (39 pS; four out of five patches) and an area of
7868%.
Because the amplitude histograms in panel B are based on
openings, they emphasize the contribution of channels that open
in prolonged bursts of many openings, such as the low
conductance, putative two-a receptors. It is informative to re-plot
these data counting the number of bursts for each conductance (of
course, neither method allows us to estimate the number of
channels in each subtype). Figure 6C shows that in the three 9:1
patches that did have low conductance openings, only a small
proportion of bursts, 7.861.8% (n=3), belong to low conductance
channels. Figure 6D quantifies another property of these two
classes of channels, namely that the smaller openings always occur
in distinctive long bursts (176645 ms and 98616 ms for the 1:9
and 9:1 transfections, n=7 and 3 patches, respectively). The
higher conductance of 39 pS, which predominates in 9:1 cells, has
a shorter burst length of 1462 ms.
Discussion
Depending on expression system and a:b subunit ratios,
recombinant a3b4 neuronal nicotinic receptors contain either
two or three copies of the a subunit. This is similar to a4b2
Table 2. Effects of the 99 LT mutation on the ACh dose-response curve of human a3b4 receptors expressed in oocytes at extreme
ratios.
a:b ratio Subtype EC50 (mM) Imax (nA) Hill slope Potency ratio
Square root of
potency ratio
Cube root of
potency ratio n
1:1 a3b4 17268.4 20506301 1.5660.07 1 - - 5
1:9 a3b4 138613.7 12706316 1.7960.14 1 - - 4
a3LTb4 4.4860.38 10606238 1.3360.09 36.8 [33.8–40.0] 6.1 [5.8–6.3] - 5
a3b4LT 0.9260.13 226654 0.9060.12 - - 4
9:1 a3b4 309627.8 6866213 2.4160.21 1 - - 4
a3b4LT 37.761.70 7206264 1.9160.10 9.6 [8.88–10.3] 3.1 [2.98–3.21] - 3
a3LTb4 7.2160.21 15806407 1.9160.05 46.80 [43.7–50.1] - 3.6 [3.52–3.69] 5
EC50, Imax and Hill slope are means 6 standard error of the mean of separate fits of each dose-response curve to the Hill equation. Potency ratios are expressed relative
to the wild-type curve and were estimated from parallel fits to the Hill equation (note that the dose-response curve for the 1:9 a3b4LT receptor was too shallow to allow
parallel fits do be done without too much distortion, see also [13]. The 2-unit likelihood intervals for the potency ratios are shown in brackets.
doi:10.1371/journal.pone.0013611.t002
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receptors, except that a3b4 channels favour the three-a form in
HEK cells and the two-a form in oocytes. The two forms are
similar in agonist sensitivity and agonist potency, but only the
putative two-a form is susceptible to enhancement by low zinc
concentrations. Furthermore, the two stoichiometries are mark-
edly different in both single-channel conductance and kinetics.
The two forms of the a3b4 receptor have different a:b
stoichiometry
Early suggestions that neuronal nicotinic receptors exist in
different stoichiometries [8,15] were proven for a4b2 receptors
[7], where the two forms differ by up to 100-fold in ACh sensitivity
[9,17,18].
Heterogeneity in the properties of a3b4 receptors across
expression systems may also be explained by different stoichiom-
etries [6]. This is supported by several lines of evidence. Firstly, the
effects of the 99 LT mutation are different in the two expression
systems and in oocytes they depend on a:b cRNA ratios. In the
past we showed by this approach that a single copy of b3 is
incorporated in a3b4b3 nicotinic receptors [13], a finding recently
confirmed by detecting FRET between subunits bearing appro-
priate fluorescent probes [19]. In the present experiments, EC50
shifts were consistent, with a roughly linear relation between log
EC50 and number of mutation copies (Figure 3). A second line of
evidence comes from the effects of zinc, which enhances only the
putative two-a form. In a4b2 receptors, Zn2+ potentiation requires
an a4(+)/a4(2) interface, present only in the three-a form. The
key two residues on the opposite sides of the interface are a4
His165 (Loop F,2 side) and a4 Glu194 (Loop C, + side) [10]. The
question is which subunit interface mediates zinc enhancement in
the a3b4 receptor. It cannot be the b4(+)/a3(2) interface (present
in both stoichiometries), but it cannot be the a3(+)/a3(2) interface
either (present only in the three-a form), as it lacks the key residues
identified in a4. By exclusion, it would seem that the b4(+)/b4(2)
interface could mediate Zn2+ potentiation, as it is present only in
the two-a stoichiometry. This hypothesis could be tested by site-
directed mutagenesis.
Macroscopic properties of the two forms of the a3b4
receptor
a4b2 receptors from 1:1 a:b transfections are a mixture of
stoichiometries, but three-a, low-sensitivity channels predominate
[7,9,18]. Contrary to that, for a3b4 channels from 1:1 a:b ratios, the
putative two-a form is the predominant one in oocytes and the
three-a in HEK cells. The different behaviour could be due to
differences in the binding of a3 and a4 to chaperone proteins (such
as 14-3-3, known to affect the proportion of the two forms of a4b2
[20], given that the a-subunit intracellular domain is not conserved.
The two forms of the a4b2 receptor differ greatly in
pharmacology, cation permeability and response to chronic
nicotine [7,9,21,22]. Remarkably, this is not the case for a3b4
receptors, at least at macroscopic level. In oocytes, overexpressing
the a subunit decreases acetylcholine sensitivity by less than three-
fold. The main difference between the two forms is in the relative
potency of DMPP, which is equipotent with acetylcholine on the
putative two-a form and 10-fold more potent on the putative three-
a form. Interestingly, the rank order of potency of DMPP is also
one of the main differences between recombinant and native
receptors of this type. Receptors from the soma of autonomic
ganglion neurons are most sensitive to cytisine, followed by DMPP
and ACh [4,23,24], a sequence that is not reproduced by rat
subunits expressed in oocytes, and is seen only in a fraction of stably
transfected fibroblasts [4,6]. DMPP is unlikely to be a useful tool in
practice, because it is more potent on the low-sensitivity form of the
receptor and this reduces the difference in potency in absolute
terms. Extrapolation to EC50s, assuming identical efficacy, suggests
that DMPP would have an EC50 of 30 and 140 mM on the putative
three-a and two-a forms, respectively. For a4b2 receptors the
difference in potency between the two forms varies widely across
agonists (from complete lack of selectivity to 100-fold difference
[9]), so a3b4 agonists with better discrimination may yet be found.
Single-channel properties of the two forms of the a3b4
channel
The putative two-a form of the channel opens to much longer
bursts (100 ms or more vs 14 ms) with smaller conductance (26 vs
Figure 3. Relationship between the average EC50 values and
the presumed number of 99 LT mutations. Each point is plotted
according to the stoichiometry we suggest for each cell type and
subunit ratio. The assumed stoichiometry is stated on the plot. The
linear relationship between the EC50 values and the number of mutated
subunits confirms that the stoichiometry we assume is plausible.
doi:10.1371/journal.pone.0013611.g003
a3b4 Receptor Stoichiometry
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39 pS) than the three-a form. Thus, it resembles the predominant
type of opening that we described after 1:1 expression of rat a3b4
receptors in oocytes and in stably-transfected fibroblasts [5,6] and
may account for the slow kinetics of rat a3b4 receptors in voltage-
jump relaxations [25]. Channels similar to the putative three-a form,
rare in oocytes, are more common, but still a minority, in stably-
transfected fibroblasts. This form resembles neuronal nicotinic
receptors recorded from rat superior cervical ganglion [5,26,27].
Ganglionic receptors are thought to contain a3 and b4 possibly with
a5 [28] especially in somatic receptors [24] but see [29] and mediate
fast excitatory synaptic events, which have a time course similar to
the burst length of the putative three-a form (cf 13.9 ms [30]) and
certainly much shorter than that of the two-a form.
Our results differ from those of a previous study [29] that found
that oocyte-expressed a3b4 receptors had mostly short bursts,
unless expressed with a5. It is difficult to compare the expression
conditions, as subunit ratios are not specified and plasmid
construction is different (in the ones we employ, the original
untranslated regions were removed and replaced by those of b-
globin). Conductance comparisons with this and other studies (see
[12]) are impossible when the recording solutions contain different
concentration of divalent ions (especially calcium, which affects
both nicotinic conductance and kinetics [31]).
In nicotinic channels, conductance is controlled by three rings
of charges in the pore-lining M2 domain [32] and by residues in
an M3–M4 loop amphipathic helix that lines the intracellular
fenestrations of the channel [33]. Because a3 and b4 differ at
position 209 in M2 (Glu vs. Lys), a channel containing three a
subunits would have an overall negative charge (21) in this ring
and one containing two a subunits would carry an overall positive
charge (+1). In the muscle receptor, mutations that produce the
same difference in charge in this positions decreased conductance
by 20% [32]. These subunits differ also in the intracellular
amphipathic helix. At the 249 position, a3 has a Gln and b4 an
Asp and at the 09 position a3 has a Lys and b4 a Gln residue.
These differences would be expected to oppose the effects of the
M2 residues on conductance, but it is difficult to estimate by how
much (only charge reversals have been tested in the equivalent
positions of a4b2 [34]). Our results would suggest that M2 residues
have the greater effect.
Figure 4. The two different receptor stoichiometries expressed in oocytes differ in their DMPP sensitivity. The traces in (A) are
examples of inward currents elicited by low agonist concentrations (in mM) and recorded from oocytes injected with a subunit ratio of 1:9 (top traces)
and 9:1 (bottom). The duration of each agonist application is shown above each trace (solid bar). All agonists (CCh, carbachol; EPB epibatidine; Nic,
nicotine; DMPP, dimethylphenylpiperazinium; Cyt, cytisine; LOB, lobeline) were tested on the same oocyte (held at 270 mV), with the exception of
lobeline (shown on the right, recorded from a different cell but with similar initial ACh current as the cell on the left, for both subunit ratios). The log-
log plots in (B) are partial dose-response curves for the experiments shown in A (left). Note the increase in the potency of DMPP (10-fold leftward shift
of the dose-response curve) in the 9:1 ratio.
doi:10.1371/journal.pone.0013611.g004
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It is interesting to note the profound difference in kinetics
between the two forms of the receptor. The difference in
stoichiometry potentially means a different number of binding
sites, and it may be that the a3(+)/a3(2) interface can function as
an agonist binding site, a hypothesis that warrants further
investigation (the Hill slope of the dose-response curve of the
putative three-a form is higher, but this could stem from any
number of changes in the kinetic mechanism [35].
Our data show that the a3b4 neuronal nicotinic receptor can
exist in two forms that differ in stoichiometry. This may be a
general phenomenon for heteromeric neuronal nicotinic receptors
which can form from the expression of one a and one b subunit. It
will be important to assess if native channels can exist in different
stoichiometries (or whether this possibility is abolished by the
additional subunits native channels may contain) and whether that
has physiological or pharmacological consequences.
Note added in print:
During the revision of this manuscript, a report was published
showing that, in substantial agreement with our findings, oocyte
expression of rat a3b4 neuronal nicotinic receptors gives rise to a
mixture of three-a and two-a receptor forms which have differ in
their sensitivity to isomers of a-conotoxin AuIB (Grishin AA,
Wang CI, Muttenthaler M, Alewood PF, Lewis RJ et al. (2010) a-
conotoxin AuIB isomers exhibit distinct inhibitory mechanisms
and differential sensitivity to stoichiometry of a3b4 nicotinic
acetylcholine receptors. J Biol Chem 285: 22254–22263).
Materials and Methods
Preparation of cDNA and cRNA constructs
cDNAs for the human a3 and b4 nAChR subunits (GenBank
accession numbers Y08418 and Y08416, respectively) containing
the coding sequences and an added Kozak consensus sequence
(GCCACC) immediately upstream of the start codon were
subcloned into the pcDNA3.1 vector (Invitrogen, Breda, The
Netherlands) for expression in human embryonic kidney 293
(HEK293) cells. The 99 LT mutated subunits (a3L279T and
b4L272T, where L stands for leucine and T stands for threonine;
referred from here on as a3LT and a3LT), were created using the
QuickChangeTM Site-Directed Mutagenesis Kit (Stratagene) and
their full-length sequence was verified.
For expression in oocytes, all cDNAs were subcloned into the
pSP64GL vector, which contains 59 and 39 untranslated regions
(UTRs) for the Xenopus b-globin. The cDNA/pSP64GL plasmids
were linearized immediately downstream of the 39 UTR, and
capped cRNAs were transcribed using the SP6 mMessage
mMachine kit (Ambion, Cambridge, UK). The quality of the
cRNA molecules was checked by RNA gel-electrophoresis and by
comparison with RNA size and concentration markers.
HEK293 cell culture and transfection
HEK293 cells (ATCC-CRL-1573; American Type Culture
Collection) were maintained in a 95% air/5% CO2 humidified
incubator at 37uC in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 0.11 g/L sodium pyruvate, 10%
(v/v) heat-inactivated foetal bovine serum, 100 U/ml penicillin G,
100 mg/ml streptomycin sulphate, and 2 mM L-glutamine (all
from Invitrogen, Breda, The Netherlands). Cells were passaged
every 2–3 days (up to 20 times) and were plated on polylysine-
coated coverslips in 35 mm culture dishes, approximately 24 hrs
before transfection with a calcium phosphate-DNA co-precipita-
tion method [36]. Cells were transfected with cDNA mixtures for
a3b4, a3LTb4 or a3b4LT. For whole-cell recordings the a3 to b4
cDNA ratio in the mixtures was kept equal (1:1), whereas for
single-channel recordings we used extreme ratios of 1:9 or 9:1 of
wild-type subunit cDNAs. In all cases, plasmid coding for the
marker enhanced green fluorescent protein (eGFP-c1; BD
Biosciences, Oxford, UK) was also co-transfected in order to
visualise successfully transfected cells. Each culture dish was
transfected with 2–3 mg of DNA; this amount was enough for a
high rate of transfection efficacy [36]. All recordings were
performed 14–48 hrs after transfection, at room temperature.
Xenopus oocyte preparation and cRNA injection
Female Xenopus laevis frogs, anaesthetized by immersion in
neutralized ethyl m-aminobenzoate solution (tricaine, methane-
sulphonate salt; 0.2% solution w/v, Sigma), were killed by
Table 3. Potency ratio values for a range of nicotinic agonists on human a3b4 neuronal nicotinic receptors expressed in oocytes.
a:b ratio Agonist Potency ratio 95% confidence intervals Log-log slope n
1:9 Epibatidine 62906815 [4820–9060] 1.3560.05 8
Lobeline 7.3560.56 [6.20–9.03] 1.0660.09 8
Nicotine 1.4360.14 [1.16–1.86] 1.4360.06 8
Cytisine 1.4060.15 [1.13–1.82] 1.0760.04 10
ACh 1 - 1.4560.07 22
DMPP 0.9960.02 [0.95–1.05] 1.2160.08 9
Carbachol 0.09460.003 [0.088–0.100] 1.0760.09 12
9:1 Epibatidine 62606573 [5110–8070] 2.0460.17 7
Lobeline 17.762.22 [13.4–26.1] 2.0460.17 6
Nicotine 2.9560.14 [2.65–3.33] 2.3360.11 9
Cytisine 1.9260.16 [1.58–2.46] 1.7760.11 6
ACh 1 - 2.1960.13 19
DMPP 10.260.62 [8.91–11.9] 2.3160.10 8
Carbachol 0.09360.004 [0.083–0.102] 2.3760.15 6
Numbers shown are average values 6 standard error of the mean. Potency ratios, relative to the standard agonist ACh, express how much more potent than ACh an
agonist is at a comparable level of response. The 2-unit likelihood intervals for the potency ratios are shown in brackets.
doi:10.1371/journal.pone.0013611.t003
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concussion immediately followed by decapitation and destruction
of the brain and spinal cord before removal of the ovarian lobes.
This procedure is in accordance with United Kingdom Home
Office regulations. The study protocol does not fall under the
remit of the UCL Research Ethics Committee (see http://www.
ucl.ac.uk/research/images/research-ethics-framework).
Clumps of stage V–VI oocytes were dissected in a sterile
modified Barth’s solution consisting of (in mM): 88 NaCl, 1 KCl,
0.82 MgCl2, 0.77 CaCl2, 2.4 NaHCO3, 15 Tris-HCl, with 50 U/
ml of penicillin and 50 mg/ml of streptomycin (Invitrogen, Breda,
The Netherlands) in HPLC water; pH 7.4, adjusted with NaOH.
The dissected oocytes were treated with collagenase (type IA,
Sigma; for 50–65 minutes at 18uC, 245 collagen digestion units/
ml in Barth’s solution, 10 to 12 oocytes per ml), then rinsed and
stored at 4uC overnight. Treated cells were manually defolliculated
the following day prior to cRNA injection. The cRNA mixtures of
a3b4, a3LTb4 or a3b4LT (in a a3:b4 ratio of 1:9 and 9:1) were
injected into oocytes using a Nanoject Automatic Oocyte Injector
(Drummond Scientific, Broomall, PA). The total amount of cRNA
injected (in 46 nl of RNase-free water, 0.25–10 ng/cell) was
determined empirically, with the aim of achieving a maximum
ACh-evoked current no greater than 2 mA, in order to contain the
magnitude of series resistance errors in our recordings. After
injection, the oocytes were incubated for ,48–60 hrs at 18uC in
fresh Barth’s solution containing 5% heat-inactivated horse serum
(Invitrogen, Breda, The Netherlands) and stored at 4uC.
Experiments were carried out at 18uC, 2.5 to 5 days from
injection.
Two-electrode voltage clamp recordings from Xenopus
oocytes
Oocytes, held in a 0.2 ml bath, were perfused at 4.5 ml/min
with modified Ringer solution containing (in mM): 150 NaCl, 2.8
KCl, 10 HEPES, 2 MgCl2 and 0.5 mM atropine sulphate; pH 7.2,
adjusted with NaOH. The solution was (nominally) calcium-free in
order to minimize the activation of calcium-gated chloride
channels (endogenous to the oocyte) by calcium entry through
nicotinic channels. Oocytes were held at 270 mV using the two-
electrode clamp mode of an Axoclamp-2B amplifier (Molecular
Devices, CA, USA). Electrodes were pulled from thin-walled Clark
Figure 5. The two-a and three-a form of the a3b4 receptor differ in their response to Zn2+ modulation. Traces in (A) are typical currents
activated by an EC20 concentration of ACh on the two-a receptor (left, 1:9 a:b ratio) and the three-a receptor (right, 9:1 ratio) in the presence of
increasing concentrations of Zn2+. Zn2+ was pre-applied to oocytes for 30 s before it was applied together with ACh. (B) Zn2+ concentration-response
curves for the three-a receptor (filled squares) and the two-a receptor (filled circles). Curves from different cells were pooled and fitted to the Hill
equation and to the sum of two Hill equations, respectively. Note that Zn2+ potentiated only the ACh responses of oocytes expressing the two-a
stoichiometry.
doi:10.1371/journal.pone.0013611.g005
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borosilicate glass GC150TF (Harvard Instruments) and were back-
filled with 3 M KCl (resistance of 0.5–1 MV on the current-
passing side).
Agonist solutions (freshly prepared from frozen stock aliquots)
were applied via the bath perfusion at 5 min intervals for a period
sufficient to obtain a stable plateau response (at low concentra-
tions) or the beginning of a sag after a peak (at the higher
concentrations). The 5 min intervals were sufficient to ensure
reproducible responses. Agonist responses were recorded on a flat
bed chart recorder (Kipp & Zonen, Lincoln, UK) for later analysis.
A standard concentration of ACh (approximately EC20) was
applied every third response to monitor agonist sensitivity
throughout the experiment and allow correction of the data for
rundown, as described previously [13]. Experiments were started
only after checking that this standard concentration gave
reproducible responses. For ACh dose-response curves, a de-
scending dose protocol was used.
For the potency-ratios experiments, low agonist concentrations
were tested in each cell in order to obtain partial concentration-
response curves (2–3 points for each agonist). The purpose of this
was to reduce the impact of desensitization and agonist self-block
and to ensure that the slope of all agonist curves was similar when
Figure 6. Single-channel properties of a3b4 receptors expressed from extreme ratios in HEK293 cells. (A) Examples of outside-out
currents elicited by 5 mM ACh, from cells transfected with an a3 to b4 cDNA ratio of 1:9 (left) and 9:1 (right). Patches were held at 2100 mV. The
histograms of fitted amplitudes corresponding to these recordings are shown in (B). These are fitted with Gaussian curves to give the peak current
amplitudes and the areas under each curve (for these two patches the values are 2.760.3 pA, area 100% for 1:9; 2.660.5 pA, area 27% and
3.960.4 pA, area 73% for 9:1). The histogram on the left (C) shows the proportion of bursts (as % of the total number of bursts from all experiments,
pooled) at each chord conductance for the two subunit ratios. The histogram on the right (D) shows the difference in the duration of the bursts to
different conductances for the two ratios.
doi:10.1371/journal.pone.0013611.g006
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dose-response curves were plotted on double-logarithmic coordi-
nates. Care was also taken to match the size of the responses to
different agonists. In all cells, ACh was used as the standard
agonist. The maximum agonist concentrations for the 1:9 and the
9:1 ratio of a3 to b4were, respectively: 10 nM and 20 nM for
epibatidine; 10 mM and 2 mM for lobeline; 25 mM and 5 mM for
1,1-dimethyl-4-phenylpiperazinium iodide (DMPP); 20 mM for
nicotine and cytisine; 50 mM for ACh; 0.5 mM and 1 mM for
carbachol.
The effect of Zn2+ was assessed by co-applying increasing
concentrations of Zn2+ together with ACh (at its EC20 concentra-
tion, 120 and 50 mM ACh for the 9:1 and 1:9 a:b ratios,
respectively). Before each application, oocytes were preincubated
for 30 s with Zn2+ alone. ACh responses in the presence of Zn2+
were normalised to the response from ACh alone, at the same
concentration.
Whole-cell recordings from HEK293 cells
Whole-cell recordings from transfected HEK293 cells were
performed with an Axopatch 200B amplifier (Molecular Devices,
CA, USA) at a holding potential of 230 mV. Cells were
superfused with extracellular solution containing (in mM): 120
NaCl, 3 KCl, 3 HEPES, 2 CaCl2, 2 MgCl2, 25 D-glucose, pH 7.4
(adjusted with Tris base). Electrodes (2–4 MV final resistance)
were pulled from thin-walled borosilicate glass GC150TF
(Harvard Instruments) and backfilled with a solution containing
(mM): 110 Tris-phosphate dibasic, 28 Tris-base, 11 EGTA, 2
MgCl2, 0.1 CaCl2, 4 Na-ATP, pH 7.3 (adjusted with Tris base).
This K+-free intracellular solution was adopted in order to
minimize the receptor rundown during recording [37]. Series
resistance (between 4–10 MV) was routinely compensated to 80–
95%. Agonist solution (freshly prepared from frozen ACh stock
aliquots), was applied through a modified U-tube system with
solution exchange times of the order of 2–6 ms, measured by
recording the open tip potential change to the application of a
50% diluted extracellular solution before the experiment. Different
ACh concentrations were applied at 2 min intervals in a random
order and a standard concentration of ACh (,EC20) was applied
every third response in order to allow us to monitor for rundown.
Whole-cell records were filtered at 0.5 kHz and digitized at
2 kHz to a computer with a Digidata 1322A interface and
Clampex software (both from Molecular Devices, CA, USA).
Single-channel recordings
Recordings from HEK293 cells were performed in the outside-
out configuration at 2100 mV. The extracellular solution
contained (in mM): 150 NaCl, 1.1 KCl, 2 MgCl2, 1 CaCl2, 10
HEPES, pH 7.2 (adjusted with NaOH). Electrodes were pulled
from thick-walled Clark borosilicate glass GC150F (Harvard
Instruments), coated near the tip with Sylgard 184H (Dow
Corning, UK) to improve their dielectric properties and fire-
polished prior to use, to a final resistance of 8–12 MV. Electrodes
were filled with high potassium intracellular solution to minimise
the contribution of potassium channels at the holding potential
used for recording (2100 mV). The solution contained (in mM):
107.1 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 11 EGTA, 20 TEACl,
2 MgATP (pH was adjusted to 7.3 with KOH and osmolarity was
corrected to 320 mOsm with sucrose when needed).
Single-channel currents, elicited by the application of 5 mM
ACh, were recorded with an Axopatch 200B amplifier, prefiltered
at 10 kHz (using the 4-pole Bessel filter of the amplifier) and stored
on a DAT tape (Bio-Logic Science Instruments, Claix, France).
For off-line analysis, recordings were played back from the tape,
filtered at 0.5–2 kHz with a 8-pole Bessel filter, and digitized to a
computer with a sampling rate of 30 kHz, using a Digidata 1322A
and Clampex.
Data Analysis: whole cell responses
ACh dose-response curves obtained either from HEK293 cells
or oocytes, and also Zn2+ dose-response curves from oocytes were
fitted with the Hill equation:
I~Imax
A
nH
EC50
nHzAnH
ð1Þ
where I is the current response, measured at its peak, Imax is the
maximum response, A is the agonist concentration, EC50 is the
agonist concentrations for 50% maximum response and nH is the
Hill coefficient. The program CVFIT, courtesy of D. Colquhoun
and I. Vais, (available at http://www.ucl.ac.uk/Pharmacology/
dc.html) was used for least square fitting. Data for each cell or
oocyte were fitted separately to give the values for Imax, EC50, and
nH in the Tables (shown as mean 6 standard error of the mean).
In order to estimate the shift in the dose-response curve caused
by the 99 LT mutation, individual curves were normalised each to
its fitted maximum and pooled, to give one normalised curve for
each receptor combination. These sets were then fitted again
simultaneously with the Hill equation, with the constraint of
having equal Hill slopes (‘‘parallel’’ fits). From the parallel fits, the
program could estimate the distance between the wild-type and
mutant curves (i.e. the dose ratios, see Table 1) and the 2.01-unit
likelihood intervals for the dose ratios, which are equivalent to a
confidence interval of 62 standard deviations for a Gaussian
variable [38].
For the potency ratios experiments, all partial dose-response
curves obtained from each oocyte were fitted simultaneously with
equal weighting, using CVFIT, with power functions constrained
to be parallel. This is equivalent to fitting the dose-response curves
with a Hill equation, with the constraint of having a Imax which is
much higher than the responses analysed (see equation 1; as
Figure 2 shows, the responses to the concentrations of the standard
agonist used in these experiments, ACh, were less than 10% of
Imax); at low concentrations, the slope of this log-log plot
(Figure 4B) tends to the value of the Hill slope. For each cell,
dose ratios for each agonist were estimated relative to ACh (equal
to dose ratio of 1). Potency ratios for each agonist are the
reciprocals of the dose ratios (i.e. equivalent to saying that each
agonist is x times more potent than ACh). Errors and confidence
intervals for potency ratios were calculated using Fieller’s theorem
[39]. In order to confirm that the curves were indeed parallel, all
data were also fitted without the constraint of parallelism to obtain
the slope for each individual agonist (Table 3).
The dose-response curve to zinc was fitted to the sum of two
Hill equations (parameterised as logistic equation by the fitting
program Prism 5.01, GraphPad Software, San Diego, USA):
I~Minz
w(Max{Min)
1z
EC50
nH1
½Zn2znH1
z
(1{w)(Max{Min)
1z
IC50
nH2
½Zn2znH2
ð2Þ
where I is the ACh response, measured at its peak and normalized
to the value in the absence of Zn2+, w is a fitted coefficient between
0 and 1 that gives the weight of the first component, Max and Min
are fitted parameters that express the maximum enhancing or
inhibiting effect of Zn2+ (as a fraction of the control response),
EC50 and IC50 are the Zn
2+ concentrations for 50% maximum
enhancement or inhibition, respectively, nH1 and nH2 are the Hill
coefficients of the two components and x is log10 [Zn
2+]. Data from
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each experiment were fitted separately and the resulting EC50
values were used to obtain the mean EC50 and the standard error
of the mean reported in the text. For the experiments in Figure 5B,
the fitted values of w, Max and Min were 0.31, 1.78 and 20.83,
respectively.
Data analysis: single channels
The recordings chosen for single-channel analysis were
idealized by time-course fitting using the program SCAN. After
choosing and imposing the appropriate resolution (40–200 ms),
fitted amplitude diagrams were created and fitted with the
appropriate number of Gaussian curves using EKDIST (both
programs are available at http://www.ucl.ac.uk/Pharmacology/
dc.html). More than 100 openings were used from each
experiment and these openings were included only if they were
longer than twice the rise time of the filter and therefore had well-
defined amplitudes. Current amplitudes were converted into chord
conductances, assuming a reversal potential of 0 mV (with no
correction for junction potential). For patches with both high- and
low-conductance openings, burst duration was analysed separately
for the two channels.
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